Search Results - "M. V. ZHURAVLEVA"

Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma by Zyryanov, S K, Avdeev, S N, Ivanov, D A, Zhuravleva, M V, Kniajeskaia, N P, Matveev, N V, Nenasheva, N A, Fomina, D S, Frolov, M I

“…During last few years, the approaches to the management of patients with severe asthma have been revised. Monoclonal antibodies (MABs), inhibitors of…”
Get full text

Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma by Kolbin, A S, Avdeev, S N, Zhuravleva, M V, Gomon, Yu M, Balykina, Yu E, Matveyev, N V, Proskurin, M A, Fedosenko, S V

“…Asthma is a heterogeneous chronic disease of airways. One of its endotypes is eosinophilic asthma, accompanied by both peripheral blood and airway…”
Get full text

Methodology for Creating a Risk Management System for Drug-Drug Interactions by A. A. Taube, M. V. Zhuravleva

“…Drug-drug interactions (DDIs) are a major cause of hospital admissions, accounting for 16.6% of ADRs and about 1% of all hospital admissions. Polypharmacy is…”
Get full text

Readers’ preferences of Irkutsk residents in late of XIX–early XX centuries by Zhuravleva, M. V.

“…The article deals with the problem of the reader and reading among the urban population, which is little studied in Russian history. Based on the analysis of…”
Get full text

Cost-effectiveness of dapagliflozin as part of various treatment regimens for prevention of cardiovascular death and achieving the target indicator "Reduction of cardiovascular mortality" of the State Program "HealthCare Development" in patients with heart failure with reduced ejection fraction by Zhuravleva, M. V., Nedogoda, S. V., Gagarina, Yu. V., Marin, T. V.

“…Aim. To evaluate the dapagliflozin as part of various treatment regimens in patients with heart failure (HF) with reduced ejection fraction (HFrEF) ≤40%…”
Get full text

Clinical and economic analysis of the use of the medicinal product dapagliflozin in patients with chronic heart failure and type 2 diabetes mellitus by Zhuravleva, M. V., Gagarina, J. V., Marin, T. V.

“…OBJECTIVE: Clinical and economic evaluation of using the dapagliflozin in addition to standard therapy for patients with CHF (Chronic Heart Failure) and…”
Get full text

Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia by Taube, A. A., Alexandrova, T. V., Demidova, O. A., Zhuravleva, M. V.

“…Background. The global recommendations for the treatment strategy of community-acquired pneumonia (CAP) include the empirical prescription of antibiotic…”
Get full text

Antioxidant enzymes and reactive oxygen species level of the Achromobacter xylosoxidans bacteria during hydrocarbons biotransformation by Sazykin, I. S., Sazykina, M. A., Khmelevtsova, L. E., Seliverstova, E. Yu, Karchava, K. Sh, Zhuravleva, M. V.

“…The level of catalase and superoxide dismutase induction, as well as generation of superoxide anion radical in cells and accumulation of hydrogen peroxide in…”
Get full text

A relationship between analgesic and neurotropic effects by the example of milgamma by Zhuravleva, M V, Shikh, E V, Makhova, A A

“…Combined vitamin preparations containing thiamine (vitamin B1), pyridoxine (vitamin B6), and cyanocobalamin (vitamin B12) are widely used in medical practice…”
Get full text

Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy by Zhuravleva, M. V., Chulanov, V. P., Gagarina, Yu. V., Shabalina, E. A.

“…Objective : to evaluate the pharmacoeconomic feasibility of using monoclonal antibodies or their combinations vs standard therapy in patients with mild and…”
Get full text

Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow by Kuznetsova, E. V., Zhuravleva, M. V., Mikhailov, I. A., Kurnosova, T. I.

“…Objective : development of approaches to predict the likelihood of adverse reactions (ARs) when using drugs based on a comprehensive assessment of risk…”
Get full text

Assessment of The Toxicological Profile of The New Dioxidine Dosage Form (Solution for Topical and External Use, 0.025%) by M. V. ZHURAVLEVA, E. A. ROSHCHINA, C. A. LOSEVA, A. V. GUROV

“…The general toxicity was studied with an assessment of local tolerability, immunotoxicity, and pharmacological safety of the new medicine Dioxidine®, a…”
Get full text

Contribution of ticagrelor therapy in patients with acute coronary syndrome and patients with myocardial infarction to the achievement of State Program "Health Development" target in Russia as a whole and Russian regions in 2023-2025 by Zhuravleva, M. V., Zyryanov, S. K., Paleev, F. N., Yakovlev, A. N., Gagarina, Yu. V., Marin, T. V.

“…Aim. To evaluate the contribution ticagrelor compared with clopidogrel therapy in patients with acute coronary syndrome (ACS) and patients with myocardial…”
Get full text

Cost-effectiveness of valsartan+sakubitril, dapagliflosin and empagliflosin for prevention of cardiovascular death and reducing cardiovascular mortality within the State Program "Health Development" in patients with heart failure by Zhuravleva, M. V., Tereshchenko, S. N., Paleev, F. N., Gagarina, Yu. V., Shabalina, E. A.

“…Aim . To assess cost-effectiveness of valsartan+sakubitril, dapagliflosin and empagliflosin for prevention of cardiovascular death and achieving the target…”
Get full text

Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid by Zhuravleva, M. V., Kuznetsova, E. V., Berdnikova, N. G., Prokofiev, A. B., Kameneva, T. R., Demchenkova, E. Yu

“…Scientific relevance. Vancomycin and linezolid are the antibacterial agents of choice for severe infections caused by multidrug-resistant pathogens, including…”
Get full text

Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings by Zhuravleva, M. V., Avdeev, S. N., Gagarina, Yu. V., Marin, T. V.

“…Objective : evaluation of the pharmacoeconomic feasibility of using benralizumab in the form of autoinjector (pen-injector device) in outpatient facilities…”
Get full text

Retrospective Analysis of the Initial Empirical Antibiotic Therapy Effectiveness for Community-Acquired Pneumonia in Young Individuals in Moscow Multidisciplinary Hospital by O. V. Muslimova, M. V. Zhuravleva, O. A. Demidova, G. I. Gorodetskaya, A. V. Shapchenko, E. A. Sokova

“…Despite the fact that the incidence of community-acquired pneumonia (CAP) among young people is significantly lower than among older patients, the frequency of…”
Get full text

Сost-effectiveness of preventing cardiovascular death and achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health Development" when using valsartan+sacubitril, dapagliflozin and empagliflozin in patients with heart failure with reduced ejection fraction by Zhuravleva, M. V., Tereshchenko, S. N., Zhirov, I. V., Nedogoda, S. V., Gagarina, Yu. V., Shabalina, E. A.

“…Aim . To evaluate the cost-effectiveness of achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program…”
Get full text

The Impact of Combination Therapy with Rivaroxaban and Acetylsalicylic Acid in Patients with Coronary Heart Disease on the Achievement of the Target for Reducing Mortality from Cardiovascular Diseases of the Federal Project "Fight against Cardiovascular Diseases" by Zhuravleva, M. V., Panov, A. V., Kuksenok, A. R.

“…Aim . To assess the outcomes of combination therapy with rivaroxaban and acetylsalicylic acid (ASA) in patients with stable coronary artery disease (CAD) and a…”
Get full text

Application of the cost-effectiveness method in improving the pharmacotherapy of multiple myeloma by Luchinin, E. A., Zhuravleva, M. V., Shelekhova, T. V., Bogova, V. S., Luchinina, E. V.

“…Multiple myeloma (MM) accounts for 1 % of all cancers and about 10 % of all hemoblastoses. The use of innovative technologies with the inclusion of targeted…”
Get full text